AAAAAA
Results: 1-25/35
Authors:
Zhang, ZQ
Wang, Y
Vikis, HG
Johnson, L
Liu, GJ
Li, J
Anderson, MW
Sills, RC
Hong, HL
Devereux, TR
Jacks, T
Guan, KL
You, M
Citation: Zq. Zhang et al., Wildtype Kras2 can inhibit lung carcinogenesis in mice, NAT GENET, 29(1), 2001, pp. 25-33
Authors:
DePinho, RA
Jacks, T
Citation: Ra. Depinho et T. Jacks, Tumor induction in suppressor gene knockout mice - Introduction, SEM CANC B, 11(3), 2001, pp. 175-176
Authors:
Reilly, KM
Jacks, T
Citation: Km. Reilly et T. Jacks, Genetically engineered mouse models of astrocytoma: GEMs in the rough?, SEM CANC B, 11(3), 2001, pp. 177-190
Authors:
Zhou, CY
Guo, LQ
Morriello, G
Pasternak, A
Pan, YP
Rohrer, SP
Birzin, ET
Huskey, SEW
Jacks, T
Schleim, KD
Cheng, K
Schaeffer, JM
Patchett, AA
Yang, LH
Citation: Cy. Zhou et al., Nipecotic and iso-nipecotic amides as potent and selective somatostatin subtype-2 receptor agonists, BIOORG MED, 11(3), 2001, pp. 415-417
Authors:
Tuveson, DA
Willis, NA
Jacks, T
Griffin, JD
Singer, S
Fletcher, CDM
Fletcher, JA
Demetri, GD
Citation: Da. Tuveson et al., STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications, ONCOGENE, 20(36), 2001, pp. 5054-5058
Authors:
Lipinski, MM
Macleod, KF
Williams, BO
Mullaney, TL
Crowley, D
Jacks, T
Citation: Mm. Lipinski et al., Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system, EMBO J, 20(13), 2001, pp. 3402-3413
Authors:
Cichowski, K
Jacks, T
Citation: K. Cichowski et T. Jacks, NF1 tumor suppressor gene function: Narrowing the GAP, CELL, 104(4), 2001, pp. 593-604
Authors:
Johnson, L
Mercer, K
Greenbaum, D
Bronson, RT
Crowley, D
Tuveson, DA
Jacks, T
Citation: L. Johnson et al., Somatic activation of the K-ras oncogene causes early onset lung cancer inmice, NATURE, 410(6832), 2001, pp. 1111-1116
Authors:
Geng, Y
Yu, QY
Whoriskey, W
Dick, F
Tsai, KY
Ford, HL
Biswas, DK
Pardee, AB
Amati, B
Jacks, T
Richardson, A
Dyson, N
Sicinski, P
Citation: Y. Geng et al., Expression of cyclins E1 and E2 during mouse development and in neoplasia, P NAS US, 98(23), 2001, pp. 13138-13143
Authors:
Boyd, SD
Tsai, KY
Jacks, T
Citation: Sd. Boyd et al., An intact HDM2 RING-finger domain is required for nuclear exclusion of p53, NAT CELL BI, 2(9), 2000, pp. 563-568
Authors:
Birnbaum, RA
O'Marcaigh, A
Wardak, Z
Zhang, YY
Dranoff, G
Jacks, T
Clapp, DW
Shannon, KM
Citation: Ra. Birnbaum et al., Nf1 and Gmcsf interact in myeloid leukemogenesis, MOL CELL, 5(1), 2000, pp. 189-195
Authors:
Reilly, KM
Loisel, DA
Bronson, RT
McLaughlin, ME
Jacks, T
Citation: Km. Reilly et al., Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects, NAT GENET, 26(1), 2000, pp. 109-113
Authors:
Attardi, LD
Reczek, EE
Cosmas, C
Demicco, EG
McCurrach, ME
Lowe, SW
Jacks, T
Citation: Ld. Attardi et al., PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family, GENE DEV, 14(6), 2000, pp. 704-718
Authors:
Sage, J
Mulligan, GJ
Attardi, LD
Miller, A
Chen, SQ
Williams, B
Theodorou, E
Jacks, T
Citation: J. Sage et al., Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization, GENE DEV, 14(23), 2000, pp. 3037-3050
Authors:
Attardi, LD
Reczek, EE
Cosmas, C
Demicco, EG
McCurrach, ME
Lowe, SW
Jacks, T
Citation: Ld. Attardi et al., PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family (vol 14, pg 704, 2000), GENE DEV, 14(14), 2000, pp. 1835-1835
Authors:
Lim, DJ
Rubenstein, AE
Evans, DG
Jacks, T
Seizinger, BG
Baser, ME
Beebe, D
Brackmann, DE
Chiocca, EA
Fehon, RG
Giovannini, M
Glazer, R
Gusella, JF
Gutmann, DH
Korf, B
Lieberman, F
Martuza, R
McClatchey, AI
Parry, DM
Pulst, SM
Ramesh, V
Ramsey, WJ
Ratner, N
Rutkowski, JL
Ruttledge, M
Weinstein, DE
Citation: Dj. Lim et al., Advances in neurofibromatosis 2 (NF2): A workshop report, J NEUROGEN, 14(2), 2000, pp. 63-106
Authors:
Irwin, M
Marin, MC
Phillips, AC
Seelan, RS
Smith, DI
Liu, WG
Flores, ER
Tsai, KY
Jacks, T
Vousden, KH
Kaelin, WG
Citation: M. Irwin et al., Role for the p53 homologue p73 in E2F-1-induced apoptosis, NATURE, 407(6804), 2000, pp. 645-648
Authors:
Zhang, Y
Griffith, EC
Sage, J
Jacks, T
Liu, JO
Citation: Y. Zhang et al., Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21(WAF1/CIP1), P NAS US, 97(12), 2000, pp. 6427-6432
Authors:
Wang, YH
Hayward, SW
Donjacour, AA
Young, P
Jacks, T
Sage, J
Dahiya, R
Cardiff, RD
Day, ML
Cunha, GR
Citation: Yh. Wang et al., Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue, CANCER RES, 60(21), 2000, pp. 6008-6017
Authors:
Attardi, LD
Jacks, T
Citation: Ld. Attardi et T. Jacks, The role of p53 in tumour suppression: lessons from mouse models, CELL MOL L, 55(1), 1999, pp. 48-63
Authors:
DePinho, RA
Jacks, T
Citation: Ra. Depinho et T. Jacks, A bumper crop of cancer genes, NAT GENET, 23(3), 1999, pp. 253-254
Authors:
Pasternak, A
Pan, YP
Marino, D
Sanderson, PE
Mosley, R
Rohrer, SP
Birzin, ET
Huskey, SEW
Jacks, T
Schleim, KD
Cheng, K
Schaeffer, JM
Patchett, AA
Yang, LH
Citation: A. Pasternak et al., Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization, BIOORG MED, 9(3), 1999, pp. 491-496
Authors:
Yang, LH
Morriello, G
Leung, K
Jacks, T
Cheng, K
Schleim, KD
Smith, R
Patchett, AA
Citation: Lh. Yang et al., Thiazole-derived potent, highly bioavailable short duration growth hormonesecretagogues, BIOORG MED, 9(13), 1999, pp. 1761-1766
Authors:
Deshaies, RJ
Jacks, T
Citation: Rj. Deshaies et T. Jacks, Cell multiplication - Peering in and peering out: regulation of and by thecell cycle, CURR OP CEL, 11(6), 1999, pp. 705-707
Authors:
Lipinski, MM
Jacks, T
Citation: Mm. Lipinski et T. Jacks, The retinoblastoma gene family in differentiation and development, ONCOGENE, 18(55), 1999, pp. 7873-7882